Tagged with Hong Kong

Hong Kong The Ming Wai Lau Center for Reparative Medicine was established in October 2016 as the first international arm of Karolinska Institute (KI) in over 200 years! What is the Center’s mission? “Hong Kong has been a trading port for centuries, and this is something Hong Kong can continue to leverage…

Hong Kong Hybribio is a very interesting company, being founded in Hong Kong and now headquartered in Guangzhou as one of the leading providers of in-vitro diagnostic (IVD) assays in Greater China with significant international presence as well. Can you tell us more about the company’s positioning today? “We have launched several…

Hong Kong William Lai YF, CEO of Fortune Pharmacal, discusses the Hong Kong OTC market, the company’s internationalization strategy, and its expanding manufacturing footprint. Could you please introduce us to Fortune Pharmacal? What sets you apart from other OTC companies? “We follow the highest standards by always exploring what the ‘big boys’…

Hong Kong Dr. Cecilia Pang, Biotechnology Director of the Hong Kong SAR Government’s Innovation and Technology Commission (ITC), discusses ITC’s mandate to develop the necessary infrastructure in order to foster Hong Kong’s innovation and technology environment, the increasing importance and relevance of the life sciences sector to Hong Kong, and the strengths…

Hong Kong Henry Yau, MD and Honorary Assistant Professor at the University of Hong Kong Clinical Trials Centre (HKU-CTC) discusses the center’s development, the diverse range of services it offers, and the clinical trials environment in Hong Kong. Having been with the organization since nearly the beginning from 2000, how have you…

Hong Kong Shawn, as I understand, SinoMab today is a clinical stage biopharma company focusing on the development of therapeutic monoclonal antibodies (mAbs) – hence the name. Can you tell us a little about the genesis of the company? Having previously studied and worked in the UK and US, I was asked…

Hong Kong Andy Barnett, general manager (Hong Kong and Macau) for Roche, discusses the highlights of his past two years managing a local affiliate instead of heading a global business line, the key factors behind Roche’s top-5 positioning in the local market, and the huge potential for innovation in aspects like digital…

Hong Kong Lawrence Wong, general manager of Ferring Pharmaceuticals in Hong Kong, discusses the important role of the Hong Kong affiliate in support of regional operations, the value of the Hong Kong market given that Ferring offers most of its global portfolio here, and how the company philosophy ‘People come first at…

Hong Kong William Yim and Kelvin Chiu of Sanwa Biotech discuss their innovative company’s impressive growth and the environment for biotech start-up companies in Hong Kong. Despite only having been founded five years ago in 2012, Sanwa BioTech has seen tremendous progress. Can you highlight some of the main development milestones? “Our…

Hong Kong The Hon. Fanny Law Fan Chiu-fun, chairperson, and Prof. Daniel Lee, head of the Biomedical Technology Cluster, at Hong Kong Science and Technology Parks Corporation (HKSTP) discuss Hong Kong’s potential as an innovation hub, as well as the role that life sciences has to play within this. They also touch…

Hong Kong Christian Hogg, executive director and CEO of Chi-Med, discusses the company’s rapid development in tandem with the growth of the Chinese pharmaceutical market, brining genuine global pharmaceutical innovation to China, and the state of Hong Kong’s biotech industry. Hutchison China MedTech (Chi-Med) is entering a very exciting stage of its…

Hong Kong Jun Wang, founder and CEO of GeneHarbor Biotechnologies, introduces his company’s innovative technology platform and the specificities of the start-up ecosystem in Hong Kong. Dr. Wang, can you firstly tell us more about GeneHarbor’s innovative technology platform? What makes it so special? “I think that an original innovation company requires…